New approach aims to make liver cancer treatment hit tumors harder, spare healthy tissue
Disease control
Not yet recruiting
This study is testing whether a drug called angiotensin II can help a liver cancer treatment called radioembolization work better. The drug is given directly into the liver's blood supply right before the radioactive treatment beads, with the goal of steering more radiation to th…
Phase: PHASE2 • Sponsor: Niek Wijnen • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC